ScreenerHero
HomeScreenerChartsCompareGroupsMapsCommoditiesWatchlists·PricingBlog
Create free account
Sign in
ScreenerHero

The most complete stock screener for serious investors. 18,000+ stocks across US, Canada, Europe & Australia.

All systems operational
Tools
  • Screener
  • Maps
  • Commodities
  • Charts
  • Watchlists
  • Alerts
  • Calendar
  • Portfolio
Screeners
  • US & Canada
  • Nordic
  • Benelux
  • Dividend EU
  • Value EU
  • Microcap EU
  • Small Cap EU
  • Investor screens
Compare
  • vs Stockopedia
  • vs Finviz
  • vs Koyfin
  • vs TradingView
  • All comparisons
  • Alternatives
Company
  • About
  • Coverage
  • Blog
  • Help
  • Pricing
  • Affiliate Program
  • Terms of Service
  • Privacy Policy
Screeners by countryUKGermanyFranceSpainItalyNetherlandsSwitzerlandSwedenNorwayDenmarkFinlandBelgiumAustriaPortugalPolandGreeceTurkeyRomaniaCanadaMexicoAustraliaNew Zealand
Deutsch·Français·Español·Italiano

For informational and educational purposes only. Not financial advice. Market participation involves substantial risk of loss. Past performance does not guarantee future results. Always do your own research.

© 2026 ScreenerHero.com · All rights reserved
ScreenerHero

PRLD Prelude Therapeutics Incorporated

NAS · US · Healthcare · Biotechnology · preludetx.com
3.230USD-0.77%Mkt Cap: 258.63M USDP/E: —2d ago

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms, myelofibrosis (MF), polycythemia vera, and essential thrombocythemia (ET); KAT6A for the treatment of advanced breast cancer and other solid tumors; and mutated calreticulin degrader antibody conjugates to treat MF and ET. The company has collaboration with AbCellera Biologics to discover, develop, and commercialize novel degrader antibody conjugates. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.…

PRLDPrelude Therapeutics Incorporated
3.230USD-0.77%

Industry Peers

Biotechnology
Screen all Biotechnology
VRTX
Vertex Pharmaceuticals Incorporated
$130.58BUSDP/E 33.1
REGN
Regeneron Pharmaceuticals, Inc.
$95.24BUSDP/E 20.4
MRNA
Moderna, Inc.
$78.90BUSD
CSL
CSL Limited
$63.11BUSD
ARGX
argenx SE
$58.94BUSDP/E 34.3
UCB
UCB SA
$58.59BUSDP/E 24.7
ARGX
argenx SE
$58.21BUSDP/E 32.1
ONC
BeOne Medicines AG
$44.66BUSDP/E 50.1
RPRX
Royalty Pharma plc
$39.36BUSDP/E 44.7
RVMD
Revolution Medicines, Inc.
$34.87BUSD
GMAB
Genmab A/S
$31.45BUSDP/E 46.1
GMAB
Genmab A/S
$31.20BUSDP/E 42.9
INSM
Insmed Incorporated
$31.01BUSD
ROIV
Roivant Sciences Ltd.
$28.01BUSD
INCY
Incyte Corporation
$23.36BUSDP/E 58.5
BNTX
BioNTech SE
$20.07BUSD
ALNY
Alnylam Pharmaceuticals, Inc.
$19.26BUSDP/E 7.3
ASND
Ascendis Pharma A/S
$16.58BUSDP/E 17.6
EXEL
Exelixis, Inc.
$15.77BUSDP/E 19.4
BBIO
BridgeBio Pharma, Inc.
$14.81BUSD